3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
66
Rectal Neoplasms
9
Carcinoma, Non-Small-Cell Lung
8
Triple Negative Breast Neoplasms
7
Lung Neoplasms
6
Adenocarcinoma of Lung
6
Carcinoma, Intraductal, Noninfiltrating
5
Breast Carcinoma In Situ
4
Pancreatic Neoplasms
2
Unilateral Breast Neoplasms
1
Transsexualism
1
Solitary Pulmonary Nodule
1
Social Isolation
1
Recurrence
1
Piebaldism
1
Patient Satisfaction
1
Pain, Postoperative
1
Neoplastic Cells, Circulating
1
Neoplasm Micrometastasis
1
Margins of Excision
1
Lymphedema
1
Local Recurrence of Malignant Tumor of Breast
1
Inflammatory Breast Neoplasms
1
Gynecomastia
1
Gastrointestinal Stromal Tumors
1
Chordoma
1
Carcinoma, Lobular
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
COVID-19
1
Interventions
Paclitaxel
11
Carboplatin
8
Radiotherapy
6
Cyclophosphamide
6
Trastuzumab
5
Chemotherapy, Adjuvant
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
Epirubicin
3
Doxorubicin
3
Cryosurgery
3
Cisplatin
3
pertuzumab
2
Surgical Procedures, Operative
2
Radiotherapy, Conformal
2
Radiation
2
Letrozole
2
Lapatinib
2
Cryotherapy
2
Brachytherapy
2
talimogene laherparepvec
1
sargramostim
1
ferric carboxymaltose
1
atezolizumab
1
aldesleukin
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Zoledronic Acid
1
Vorinostat
1
VPS Coriolus versicolor extract
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Ductal, Breast
×
Mastectomy, Segmental
×
Clear all
NCT03909282
2026-03-12
NORDIS
Stanford University
Phase NA
Recruiting
50 enrolled